Which manufacturer produces serputinib/serpatinib?

Selpercatinib The manufacturer of the original drug belongs toEli Lilly and Company (Eli Lilly), formerly known as LOXO-292, it may also be calledRetsevmo, Ruituo, RETEVMO(Listed product name), Thisis a highly selective and potent RET kinase inhibitor with central nervous system (CNS) activity. Seputinibmay affect both tumor cells and healthy cells, causing side effects. Changes in RET drivers are primarily mutually exclusive with other oncogenic drivers.

SeputinibisU.S. Food and Drug Administration (FDA)Approved oral prescription drugs,recommended dosage120mg or 160mg depending on body weight (respectively<50kg or >50kg), taken twice daily until disease progression or unacceptable toxicity. Seputinib has been shown to be effective in treating cancers involving changes in the RET gene, includingRET fusion-positive non-small cell lung cancer, RET-altered medullary thyroid cancer, thyroid cancer, and OthersRET fusion-positive solid tumorsetc. Seputinibcan effectively reduce the tumor size in most patients.

Up to now, the original drug is sold in China as Seputinib, but it is not included in medical insurance. The price of each box of specifications80mg*56 capsules may be more than 10,000 yuan. There are European and American versions of the original drugs sold overseas, with the price of each box ranging from 20,000 to more than 100,000 yuan (prices may fluctuate due to exchange rates). Seputinib is also available overseasSeputinibGeneric drugs are on the market, and their drug ingredients are basically the same as those of original drugs sold domestically and abroad. For example, the specifications produced by Laos Pharmaceutical Factory40mg*120 pills per box are more than 4,000 yuan (the price may fluctuate due to the exchange rate).